Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

por Meyer, Saskia, Nederend, Maaike, Jansen, J.H. Marco, Reiding, Karli R., Jacobino, Shamir R., Meeldijk, Jan, Bovenschen, Niels, Wuhrer, Manfred, Valerius, Thomas, Ubink, Ruud, Boross, Peter, Rouwendal, Gerard, Leusen, Jeanette H.W.
Publicado 2015

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV

por Nederend, Maaike, van Stigt, Arthur H., Jansen, J. H. Marco, Jacobino, Shamir R., Brugman, Sylvia, de Haan, Cornelis A. M., Bont, Louis J., van Neerven, R. J. Joost, Leusen, Jeanette H. W.
Publicado 2020

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo

por Jacobino, Shamir R., Nederend, Maaike, Reijneveld, J. Frederiek, Augustijn, Daan, Jansen, J. H. Marco, Meeldijk, Jan, Reiding, Karli R., Wuhrer, Manfred, Coenjaerts, Frank E. J., Hack, C. Erik, Bont, Louis J., Leusen, Jeanette H. W.
Publicado 2018

Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness

por Mazur, Natalie I, Horsley, Nicole M, Englund, Janet A, Nederend, Maaike, Magaret, Amalia, Kumar, Azad, Jacobino, Shamir R, de Haan, Cornelis A M, Khatry, Subarna K, LeClerq, Steven C, Steinhoff, Mark C, Tielsch, James M, Katz, Joanne, Graham, Barney S, Bont, Louis J, Leusen, Jeanette H W, Chu, Helen Y
Publicado 2019